Gilead Sciences
GILD
#131
Rank
C$226.57 B
Marketcap
C$182.49
Share price
-0.82%
Change (1 day)
14.76%
Change (1 year)

Earnings for Gilead Sciences (GILD)

Earnings in 2026 (TTM): C$14.80 Billion

According to Gilead Sciences's latest financial reports the company's current earnings are C$29.73 Billion. In 2025 the company made an earning of C$13.73 Billion, an increase over its 2024 earnings that were of C$0.96 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Gilead Sciences from 1991 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$14.80 B7.84%
2025 C$13.73 B1319.86%
2024 C$0.96 B-89.94%
2023 C$9.61 B17.97%
2022 C$8.14 B-29.77%
2021 C$11.60 B395.99%
2020 C$2.33 B-67.66%
2019 C$7.23 B-33.84%
2018 C$10.93 B-42.35%
2017 C$18.96 B-20.87%
2016 C$23.96 B-21.06%
2015 C$30.35 B45.8%
2014 C$20.82 B253.01%
2013 C$5.89 B16.51%
2012 C$5.06 B-1.07%
2011 C$5.11 B-6.71%
2010 C$5.48 B11.75%
2009 C$4.90 B29.5%
2008 C$3.78 B19.11%
2007 C$3.18 B-455.74%
2006 -C$0.9 Billion-154.93%
2005 C$1.62 B76.99%
2004 C$0.91 B-266.16%
2003 -C$0.56 Billion-638.24%
2002 C$0.10 B31.5%
2001 C$78.22 M-242.15%
2000 -C$55.04 Million-40.2%
1999 -C$92.03 Million31.85%
1998 -C$69.8 Million8.73%
1997 -C$64.19 Million27.22%
1996 -C$50.46 Million
1994 -C$48.08 Million26.57%
1993 -C$37.99 Million46.49%
1992 -C$25.93 Million362.5%
1991 -C$5.61 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$36.40 B 142.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$14.84 B-1.28%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$8.37 B-44.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$43.62 B 190.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$12.73 B-15.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$2.27 B-84.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
C$1.62 B-89.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
C$7.09 B-52.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$18.43 B 22.60%๐Ÿ‡บ๐Ÿ‡ธ USA